Related Experiment Video

Updated: May 6, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.5K

[Juvenile idiopathic arthritis: from biomarker to treatment]

Charlotte M Nusman1, J Merlijn van den Berg, Dieneke Schonenberg-Meinema

  • 1Emma Kinderziekenhuis, AMC, afd. Kinderhematologie, -immunologie en -infectieziekten, Amsterdam.

Nederlands Tijdschrift Voor Geneeskunde
|November 7, 2013
PubMed

Insights

Juvenile idiopathic arthritis (JIA) is a common childhood chronic joint inflammation with unknown causes. Early MRI diagnosis and advanced therapies, including biologics, improve JIA prognosis and reduce joint damage.

Area of Science:

  • Pediatric Rheumatology
  • Medical Imaging

Background:

  • Juvenile idiopathic arthritis (JIA) is the most frequent cause of chronic joint inflammation in children.
  • Its etiology remains unknown, and pathogenesis is multifactorial.
  • JIA diagnosis is one of exclusion, requiring the ruling out of other conditions.

Purpose of the Study:

  • To highlight the increasing importance of MRI in early JIA diagnosis.
  • To discuss the role of MRI in assessing therapeutic response.
  • To outline the classification of JIA based on clinical and laboratory findings.

Main Methods:

  • Diagnosis of JIA involves excluding other disorders.
  • Magnetic Resonance Imaging (MRI) is utilized for early diagnosis and treatment assessment.
  • Classification into JIA categories follows International League of Associations for Rheumatology criteria after six months, based on clinical and laboratory data.

Main Results:

  • MRI plays a crucial role in accurate early diagnosis of JIA.
  • MRI aids in evaluating patient response to treatment.
  • Early biological treatment has improved JIA prognosis.

Conclusions:

  • Early diagnosis and intervention, including advanced imaging and therapies like biologics, significantly enhance outcomes for children with JIA.
  • Modern treatments reduce the incidence of long-term structural joint damage in JIA patients.

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.5K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
897
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
1.1K
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
51
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
79